BenevolentAI

BenevolentAI
Business Name:
BenevolentAI
Category:
Business Description:
BenevolentAI combines advanced AI and machine learning with cutting edge science to decipher complex disease biology, generate novel insights and discover more effective medicines. Our unique computational R&D platform spans every step of the drug discovery process, powering an in-house pipeline of 25+ drug programmes from early discovery towards clinical phases. With several successful collaborations with leading pharmaceutical organisations, we are also the only AI-drug discovery company with a clinically validated approach, having discovered a leading repurposed drug candidate for COVID-19. BenevolentAI is headquartered in London with a research facility in Cambridge (UK) and a further office in New York, with a team of over 300 world-leading scientists and technologists progressing its mission to reinvent drug discovery and advance life-changing drugs through to the clinic.
Based in:
London
Tags:
BioTech, Scientific Innovation, AI, MedTech
Total Funding:
No funding announced yet
Founded:
2013
Website:
www.benevolent.com

Articles about BenevolentAI:

💡 You’re a corporate or investor and looking for startups that are innovating in the same market as BenevolentAI? We’re happy to assist you with our Startup Sourcing service.